Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Med Mycol Case Rep ; 37: 13-16, 2022 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-35712462

RESUMO

Jorge Lobo's disease is a chronic granulomatous cutaneous-subcutaneous mycosis caused by the fungus Lacazia loboi, seen mainly in tropical and subtropical regions. Malignant transformation rarely occurs in this infection. In the present manuscript, we report two cases of Jorge Lobo's disease complicated by invasive squamous cell carcinoma: a 67-year-old man with a 26 -year history of Jorge Lobo's disease. In this case, the malignant tumor was surgically removed. The second case was a 75-year-old man with 22-year history of mycosis. In both patients the diagnosis of squamous cell carcinoma was confirmed by histopathological examination. There was no an immunocompromised state associated in these patients. The cases, diagnosis, complication, histopathologic findings of this disease are discussed.

2.
An Bras Dermatol ; 97(1): 93-95, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-34836741

RESUMO

Jorge Lobo's disease (JLD) is a chronic, granulomatous fungal infection caused by the traumatic implantation of the fungus Lacazia loboi in the cutaneous and subcutaneous tissues, with the presence of isolated nodular and coalescent keloidal lesions. Malignant degeneration is rare. This case report describes a 64-year-old male patient with JLD for 30-years who showed a change in the aspect of a lesion in the left lower limb. Histopathological examination confirmed the progression to well-differentiated squamous cell carcinoma (SSC). JLD is highly prevalent in tropical and subtropical regions, requiring monitoring concerning the transformation into SSC in long-term lesions.


Assuntos
Carcinoma de Células Escamosas , Lacazia , Lobomicose , Humanos , Masculino , Pessoa de Meia-Idade , Pele
3.
Mycopathologia ; 185(3): 477-483, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-32378114

RESUMO

Lacaziosis is a cutaneous chronic mycosis caused by Lacazia loboi. Macrophages are important cells in the host immune response in fungal infections. The macrophage population exhibits strong plasticity that varies according to the stimuli in the microenvironment of lesions M1 profile promotes a Th1 pattern of cytokines and a microbicidal function and M2 is related to Th2 cytokines and immunomodulatory response. We investigated the population of M1 and M2 polarized macrophages in human cutaneous lesions. A total of 27 biopsies from human lesions were submitted to an immunohistochemistry protocol using antibodies to detect M1 and M2 macrophages (Arginase-1, CD163, iNOS, RBP-J and cMAF). We could observe high number of cells expressing Arginase1, CD163 and c-MAF that correspond to elements of the M2 profile of macrophage, over iNOS and RBP-J (elements of the M1 profile). The results suggest a predominant phenotype of M2 macrophages, which have an immunomodulatory role and probably contributing to chronicity of Lacaziosis.


Assuntos
Lacazia/imunologia , Lobomicose/patologia , Macrófagos/imunologia , Antígenos CD/metabolismo , Antígenos de Diferenciação Mielomonocítica/metabolismo , Arginase/metabolismo , Biópsia , Plasticidade Celular/imunologia , Epiderme/imunologia , Epiderme/metabolismo , Epiderme/patologia , Humanos , Proteína de Ligação a Sequências Sinal de Recombinação J de Imunoglobina/metabolismo , Imuno-Histoquímica , Lobomicose/imunologia , Óxido Nítrico Sintase Tipo II/metabolismo , Proteínas Proto-Oncogênicas c-maf/metabolismo , Receptores de Superfície Celular/metabolismo
4.
Med Mycol ; 55(2): 145-149, 2017 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-27562863

RESUMO

Jorge Lobo's Disease (JLD) is a cutaneous chronic granulomatous disease caused by the pathogenic fungus Lacazia loboi. It is characterized by a granulomatous reaction with multinucleated giant cells and high number of fungal cells. In order to contribute to the comprehension of immune mechanisms in JLD human lesions, we studied the cytotoxic immune response, focusing on TCD8+ and NK cells, and granzyme B. Forty skin biopsies of lower limbs were selected and an immunohistochemistry protocol was developed to detect CD8+ T cells, NK cells and Granzyme B. In order to compare the cellular populations, we also performed a protocol to visualize TCD4+ cells. Immunolabeled cells were quantified in nine randomized fields in the dermis. Lesions were characterized by inflammatory infiltrate of macrophages, lymphocytes, epithelioid and multinucleated giant cells with intense number of fungal forms. There was a prevalence of CD8 over CD4 cells, followed by NK cells. Our results suggest that in JLD the cytotoxic immune response could represent another important mechanism to control Lacazia loboi infection. We may suggest that, although CD4+ T cells are essential for host defense in JLD, CD8+ T cells could play a role in the elimination of the fungus.


Assuntos
Lacazia/imunologia , Lobomicose/patologia , Pele/patologia , Linfócitos T Citotóxicos/imunologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Biópsia , Linfócitos T CD4-Positivos/imunologia , Feminino , Células Gigantes/imunologia , Granzimas/análise , Humanos , Imuno-Histoquímica , Células Matadoras Naturais/imunologia , Lacazia/crescimento & desenvolvimento , Macrófagos/imunologia , Masculino , Microscopia , Pessoa de Meia-Idade
5.
Med Mycol ; 54(1): 23-8, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26333354

RESUMO

Jorge Lobo's disease (JLD) is a chronic granulomatous mycosis described in various Latin American countries. The main objective of the present study was to investigate the possible role of Th17 and Foxp3+ Treg cells in the pathogenesis of Jorge Lobo's disease. Human skin biopsies were submitted to an immunohistochemistry protocol to detect Foxp3, interleukin (IL)-1beta, CD25, IL-6, IL-17, and IL-23. The epidermis presented acanthosis, hyperkeratosis, and frequent presence of fungi. The dermis presented inflammatory infiltrate comprising macrophages, lymphocytes, epithelioid and multinucleated cells, and an intense number of fungi. Foxp3+ Treg cells and IL-17+ cells were visualized in lymphocytes in the inflammatory infiltrate. IL-1, IL-2R (CD25), IL-6, and IL-23 were visualized in the dermis, intermingled with fungal cells, permeating or participating of the granuloma. Following IL-17, the most prominent cytokine was IL-6. IL-23 and cells expressing CD25 were present in fewer number. The comparative analysis between IL-17 and Foxp3 demonstrated a statistically significant increased number of IL-17+ cells. Th17 cells play a role in the immune response of JLD. IL-1beta and IL-6 added to the previously described increased number of TGF-beta would stimulate such pattern of response. Th17 cells could be present as an effort to modulate the local immune response; however, high levels of a Th17 profile could overcome the role of Treg cells. The unbalance between Treg/Th17 cells seems to corroborate with the less effective immune response against the fungus.


Assuntos
Lobomicose/patologia , Pele/patologia , Linfócitos T Reguladores/imunologia , Células Th17/imunologia , Biópsia , Feminino , Fatores de Transcrição Forkhead/análise , Humanos , Imuno-Histoquímica , Subunidade alfa de Receptor de Interleucina-2/análise , Interleucinas/análise , Masculino , Pessoa de Meia-Idade
6.
Mycopathologia ; 179(3-4): 269-74, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25487975

RESUMO

BACKGROUND: Jorge Lobo's disease (JLD) is a cutaneous chronic mycosis caused by Lacazia loboi. We studied Factor XIIIa + dermal dendrocytes (FXIIIa + DD), Langerhans cells (LC) through the expression of langerin and the expression of S100 protein. METHODS: A total of 41 biopsies and 10 normal skins (control) were developed with a polymer-based immunohistochemical method. RESULTS: Lesions presented infiltrate comprising macrophages, some asteroid corpuscles, lymphocytes, multinucleated giant cells and a large number of fungi. LCs presented short dendrites and were scarcely distributed. Dermal langerin + cells were detected in nine JLD lesions. FXIIIa + DD were hypertrophic, visualized in the inflammatory infiltrate of JLD lesions. Cells S100+ were present in JLD and control group with a similar number of cells. A total of 14 specimens did not express FXIIIa, and this considerable number probably contributed to the statistical similarity with the control group. CONCLUSIONS: The results indicate that LCs are present in the immune response against Lacazia loboi. Some dermal langerin + cells could be another subset of dendritic cells. Our data indicate changes of LCs in JLD cutaneous lesions and present, for the first time, results that show langerin + cells in the dermis and corroborate previous observations on the participation of FXIIIa + DD in the in situ immune response in JLD.


Assuntos
Células de Langerhans/imunologia , Lobomicose/patologia , Antígenos CD/imunologia , Humanos , Imuno-Histoquímica , Lacazia/isolamento & purificação , Lacazia/fisiologia , Células de Langerhans/química , Lectinas Tipo C/imunologia , Lobomicose/imunologia , Lectinas de Ligação a Manose/imunologia , Proteínas S100/imunologia , Pele/química , Pele/imunologia , Pele/patologia , Coloração e Rotulagem
7.
Acta Trop ; 114(1): 59-62, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20044969

RESUMO

Jorge Lobo's disease is a chronic infection caused by the fungus Lacazia loboi endemic in South America. The infection is characterized by the appearance of parakeloidal, ulcerated or verrucous nodular or plaque-like cutaneous lesions. The histopathological aspect is characterized by poorly organized granulomas with histiocytes and multinucleated giant cells. Little is known about local immune response in lobomycosis skin lesions. Thirty-three skin biopsies from patients with Jorge Lobo's disease were selected from Ambulatory of Dermatology, UFPA. The control group was constituted by ten biopsies from normal skin. Langerhans cells were identified by immunohistochemistry using anti-CD1a antibody (Serotec). The number of positive cells was statistically analyzed. Langerhans cells were visualized along the epidermis in biopsies from Jorge Lobo's disease and the morphology and the number of Langerhans cells did not differ from normal skin (p>0.05). In Jorge Lobo's disease, this cell population probably presents some escape mechanism of the local immune system to evade the antigen presentation by those cells.


Assuntos
Dermatomicoses/microbiologia , Dermatomicoses/patologia , Células de Langerhans/citologia , Onygenales/imunologia , Pele/microbiologia , Pele/patologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Biópsia , Dermatomicoses/imunologia , Feminino , Humanos , Imuno-Histoquímica , Masculino , Microscopia , Pessoa de Meia-Idade , Onygenales/isolamento & purificação , Pele/imunologia , América do Sul
8.
Am J Dermatopathol ; 31(6): 527-31, 2009 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-19590423

RESUMO

Leprosy is a curable chronic granulomatous infectious disease caused by the bacillus Mycobacterium leprae. This organism has a high affinity for skin and peripheral nerve cells. In the evolution of infections, the immune status of patients determines the disease expression. Dendritic cells are antigen-presenting cells that phagocytose particles and microorganisms. In skin, dendritic cells are represented by epidermal Langerhans cells and dermal dendrocytes, which can be identified by expression of CD1a and factor XIIIa (FXIIIa). In the present study, 29 skin samples from patients with tuberculoid (13 biopsies) and lepromatous (16 biopsies) leprosy were analyzed by immunohistochemistry using antibodies to CD1a and FXIIIa. Quantitative analysis of labeling pattern showed a clear predominance of dendritic cells in tuberculoid leprosy. Difference between the number of positive cells of immunohistochemistry for the CD1a and FXIIIa staining observed in this study indicates a role for dendritic cells in the cutaneous response to leprosy. Dendritic cells may be a determinant of the course and clinical expression of the disease.


Assuntos
Antígenos CD1/biossíntese , Células Dendríticas/imunologia , Fator XIIIa/biossíntese , Hanseníase/imunologia , Adulto , Células Dendríticas/metabolismo , Feminino , Humanos , Imuno-Histoquímica , Hanseníase/metabolismo , Hanseníase/patologia , Masculino
9.
Hum Pathol ; 39(2): 269-74, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17959227

RESUMO

Jorge Lobo's disease, or lacaziosis, is a chronic deep mycosis that clinically manifests as solid, variable-sized nodular parakeloidal lesions. Few studies have characterized the in situ cellular and humoral immune response, especially the involvement of cytokines with immunosuppressive effects such as TGF-beta. The objective this paper was to analyze the expression of TGF-beta in cutaneous lesions in lacaziosis and investigate its importance in the etiopathogy of the disease. The results indicate that the abundance of collagen bands, together with weak immunolabeling for CD68 seen in macrophages, indicates a concomitant effect of TGF-beta inhibiting macrophages and inducing fibrosis, which is responsible for the keloid aspect frequently acquired by these lesions. Finally, the evolution of the infection supports the hypothesis that TGF-beta plays a fundamental role in the etiopathology of Lacazia loboi infection, either by inhibiting the cellular immune response mainly mediated by macrophages or by inducing fibrosis. Further studies are necessary to better characterize the phenotype of the inflammatory infiltrate as well as the participation of other cytokines and growth factors in the tissue response of the host in Jorge Lobo's disease.


Assuntos
Imuno-Histoquímica/métodos , Macrófagos/metabolismo , Paracoccidioidomicose/metabolismo , Fator de Crescimento Transformador beta/metabolismo , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Macrófagos/microbiologia , Macrófagos/patologia , Masculino , Pessoa de Meia-Idade , Paracoccidioides/citologia , Paracoccidioides/imunologia , Paracoccidioides/isolamento & purificação , Paracoccidioidomicose/microbiologia , Paracoccidioidomicose/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...